Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC

Clinical trial NCT06663306 · RECRUITING

Trial details

NCT number: NCT06663306
Sponsor: Shanghai Chest Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)Leptomeningeal Metastasis

Start date: 2024-12-09
Primary completion: 2027-12-30
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.